Skip to main content

AVITA Medical, Inc Health Care

$5.19 0.12 (2.37%)

High

$5.29

Low

$5.12

Trades

1,945

Turnover

$3,576,754

Volume

686,116
30 June 2023 at 4:10pm
Register to track AVH and receive email alerts.
AVH Announcements on Price Chart

Latest Announcements

Headline Date
Notice under section 708A(5)(e) of the Corporations Act 30 June 2023 at 12:25pm
Notification regarding unquoted securities - AVH 30 June 2023 at 12:20pm
AVITA Medical Submits FDA PMA Supplement for RECELL GO 30 June 2023 at 9:05am
Form 8-K 27 June 2023 at 9:25am
AVITA Medical Rejoins the Russell 3000 Index 26 June 2023 at 8:50am
Notice under section 708A(5)(e) of the Corporations Act 23 June 2023 at 10:25am
Notification regarding unquoted securities - AVH 23 June 2023 at 10:20am
Notification regarding unquoted securities - AVH 22 June 2023 at 10:45am
Notice under section 708A(5)(e) of the Corporations Act 19 June 2023 at 2:40pm
Notification regarding unquoted securities - AVH 19 June 2023 at 2:35pm
AVITA Medical Announces FDA Approval of RECELL for Vitiligo 19 June 2023 at 9:00am
AVITA Medical Appointment of Chief Financial Officer 16 June 2023 at 9:05am
Change of Director's Interest Notice - Suzanne Crowe 15 June 2023 at 2:15pm
Change of Director's Interest Notice - Robert McNamara 15 June 2023 at 2:15pm
Change of Director's Interest Notice - Louis Panaccio 15 June 2023 at 2:15pm
Change of Director's Interest Notice - Jeremy Curnock Cook 15 June 2023 at 2:15pm
Change of Director's Interest Notice - Jan Stern Reed 15 June 2023 at 2:15pm
Change of Director's Interest Notice - James Corbett 15 June 2023 at 2:15pm
Change of Director's Interest Notice - Cary Vance 15 June 2023 at 2:05pm
Notification regarding unquoted securities - AVH 15 June 2023 at 2:05pm
Notification regarding unquoted securities - AVH 15 June 2023 at 2:05pm
Statement of CDIs on issue - AVH 14 June 2023 at 11:10am
AVITA Medical Receives FDA Approval for Full-Thickness Skin 8 June 2023 at 9:50am
Results of 2023 Annual Meeting of Stockholders - Updated 7 June 2023 at 11:15am
Results of 2023 Annual Meeting of Stockholders 7 June 2023 at 9:30am
Statement of CDIs on issue - AVH 7 June 2023 at 9:15am
2023 ASM Chairman Script 6 June 2023 at 4:05pm
2023 Annual Meeting of Stockholders Presentation 6 June 2023 at 4:05pm
Notification of cessation of securities - AVH 1 June 2023 at 4:15pm
Notice under section 708A(5)(e) of the Corporations Act 23 May 2023 at 9:25am
Notification regarding unquoted securities - AVH 23 May 2023 at 9:25am
Notification of cessation of securities - AVH 19 May 2023 at 9:30am
AVITA Medical Reports in U.S. Dollars 17 May 2023 at 9:05am
Q1 2023 Investor Presentation 16 May 2023 at 4:25pm
Notification regarding unquoted securities - AVH 16 May 2023 at 10:35am
AVITA Medical to Host Investor Webinar Briefing 16 May 2023 at 8:45am
Quarterly Financial Report Form 10-Q 12 May 2023 at 9:05am
AVITA Medical Reports Financial Results, Affirms FY Guidance 12 May 2023 at 8:55am
Statement of CDIs on issue - AVH 4 May 2023 at 11:05am
Notification of cessation of securities - AVH 2 May 2023 at 11:45am
AVITA Medical to Announce First Quarter 2023 Results 21 April 2023 at 8:50am
Form S-3 Registration Statement 17 April 2023 at 9:55am
Sales Agreement 17 April 2023 at 9:55am
Proposed issue of securities - AVH 17 April 2023 at 9:50am
Definitive Proxy Statement 17 April 2023 at 8:45am
AVITA Medical Announces Update to Automation Device 14 April 2023 at 8:55am
Statement of CDIs on issue - AVH 6 April 2023 at 9:15am
Notification of cessation of securities - AVH 4 April 2023 at 11:35am
Initial Director's Interest Notice - Robert McNamara 4 April 2023 at 10:40am
Initial Director's Interest Notice - Cary Vance 4 April 2023 at 10:40am
Register to track AVH and receive email alerts.